Clinical and laboratory characteristics of patients hospitalised with COVID-19: clinical outcomes in Abu Dhabi, United Arab Emirates
Research Article
Published on
Journal: BMC Infectious Diseases [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS,
Journal: BMC Infectious Diseases [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS,
[키워드] Abu
acute respiratory syndrome
affected
age
analysed
Analysis
Anti-viral therapy
average
C-reactive protein
China
Chronic kidney disease
clinical
Clinical features
Clinical outcome
co-morbidities
co-morbidity
Cohort
collected
Combination
coronavirus
coronavirus disease
COVID-19
creatinine
Diabetes Mellitus
diagnosis of SARS-CoV-2
disease
disease severity
Electronic health record
facility
ferritin
groups
health information
highest
Hospital stay
hospitalised
hospitalised patient
hypertension
in-hospital mortality rate
Infection
intensive care
interleukin-6
International
Italy
Laboratory
laboratory characteristics
laboratory feature
Laboratory test
laboratory-confirmed
lactate dehydrogenase
less
male
Mild
moderate disease
morbidity and mortality
Mortality
mortality rate
neutrophil count
Older
outcome
outcomes
Patient
patient data
patients
PCR
reported
required
Result
Retrospective analysis
SARS‐CoV‐2
service
severe group
severity
significant difference
suggested
Treatment
United Arab Emirate
Volume
with COVID-19
[DOI] 10.1186/s12879-022-07059-1 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1186/s12879-022-07059-1 PMC 바로가기 [Article Type] Research Article